​
​

Ligand Pharmaceuticals Ownership | Who Owns Ligand Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Ligand Pharmaceuticals Ownership Summary

Ligand Pharmaceuticals is owned by 97.12% institutional investors, 1.89% insiders, and 0.99% retail investors. Blackrock is the largest institutional shareholder, holding 16.19% of LGND shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.38% of its assets in Ligand Pharmaceuticals shares.

LGND Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockLigand Pharmaceuticals97.12%1.89%0.99%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.17M6.38%1.13K
Delaware Small Cap Core I655.86K3.59%-57.44K
Janus Henderson US SMID Cap Growth626.08K3.43%-
Janus Henderson Triton D626.08K3.43%-
Vanguard Total Stock Mkt Idx Inv530.75K2.83%892.00
iShares Russell 2000 ETF438.64K2.40%-980.00
Stephens SMID Select Growth425.39K2.33%1.23K
Vanguard Small Cap Index435.91K2.32%850.00
Congress Asset Mgt Small Cap Growth350.00K1.92%350.00K
Congress Small Cap Growth Institutional350.00K1.87%-

Recent Insider Transactions

DateNameRoleActivityValue
Sep 23, 2024Reardon Andrew CLO & SecretarySell$199.20K
Sep 20, 2024Espinoza Octavio Chief Financial OfficerSell$20.80K
Sep 20, 2024Espinoza Octavio Chief Financial OfficerSell$28.56K
Sep 20, 2024Espinoza Octavio Chief Financial OfficerSell$83.16K
Sep 23, 2024Korenberg Matthew E President & COOSell$248.23K

Insider Transactions Trends

DateBuySell
2024 Q3115
2024 Q2-9
2024 Q1-2
2023 Q4--
2023 Q31-

LGND Ownership FAQ

Who Owns Ligand Pharmaceuticals?

Ligand Pharmaceuticals shareholders are primarily institutional investors at 97.12%, followed by 1.89% insiders and 0.99% retail investors. The average institutional ownership in Ligand Pharmaceuticals's industry, Biotech Stocks , is 45.35%, which Ligand Pharmaceuticals exceeds.

Who owns the most shares of Ligand Pharmaceuticals?

Ligand Pharmaceuticals’s largest shareholders are Blackrock (2.87M shares, 16.19%), Vanguard group (1.93M shares, 10.87%), and Janus henderson group (1.01M shares, 5.69%). Together, they hold 32.75% of Ligand Pharmaceuticals’s total shares outstanding.

Does Blackrock own Ligand Pharmaceuticals?

Yes, BlackRock owns 16.19% of Ligand Pharmaceuticals, totaling 2.87M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 241.95M$. In the last quarter, BlackRock increased its holdings by 3.23K shares, a 0.11% change.

Who is Ligand Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Ashford capital management is Ligand Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 3.67% of its assets in 322.21K Ligand Pharmaceuticals shares, valued at 27.15M$.

Who is the top mutual fund holder of Ligand Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Ligand Pharmaceuticals shares, with 6.38% of its total shares outstanding invested in 1.17M Ligand Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools